Multiple sclerosis rebound after fingolimod discontinuation for lymphopenia

Neurological Sciences

Volumn 35, Issue 9, 2014, Pages 1485-1486

  La Mantia, Loredana ^a   Prone, Valentina ^a   Marazzi, Maria Raffaella ^a   Erminio, Cristina ^a   Protti, Alessandra ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; FINGOLIMOD; GADOLINIUM; GLATIRAMER; METHYLPREDNISOLONE; IMMUNOSUPPRESSIVE AGENT; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

ADULT; CASE REPORT; CAUCASIAN; CONTRAST ENHANCEMENT; DISEASE ACTIVITY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LETTER; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MULTIPLE SCLEROSIS; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; REBOUND; RELAPSE; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; COMPLICATION; DIAGNOSTIC USE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

ADULT; FEMALE; GADOLINIUM; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOPENIA; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROPYLENE GLYCOLS; SPHINGOSINE;

EID: 84908356380     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1800-y     Document Type: Letter

References (10)

1. Willis MA, Cohen JA (2013) Fingolimod therapy for multiple sclerosis. Semin Neurol 33:37-44
2. Vollmer T, Radue EW, Vermersch P et al (2013) Clinical and magnetic resonance imaging disease activity after fingolimd discontinuation. Abstracts book, In: 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis 2-5 October 2013 (ECTRIMS), Copenhagen, Denmark, p 548
3. Henault D, Galleguillos L, Moore C et al (2013) Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis. Neurology 81(20):1768-1772 (epub ahead of print)
4. Havla JB, Pellkofer HL, Meinl I et al (2012) Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment. Arch Neurol 69(2):262-264 (epub ahead of print)
5. Ghezzi A, Rocca MA, Baroncini D et al (2012) Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients. J Neurol 260(1):327-329
6. Gross CM, Baumgartner A, Rauer S et al (2012) Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod. Neurology 79(19):2006-2007
7. Piscolla E, Hakiki B, Pastò L et al (2013) Rebound after fingolimod suspension in a pediatric-onset multiple sclerosis patient. J Neurol 260(6):1675-1677
8. Hakiki B, Portaccio E, Giannini M et al (2012) Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases. Mult Scler 18(11):1636-1639
9. Sempere AP, Berenguer-Ruiz L, Feliu-Rey E (2013) Rebound of disease activity during pregnancy after withdrawal of fingolimod. Eur J Neurol 20(8):e109-e110
10. Tanaka M, Park K, Tanaka K (2013) Reduced fingolimod dosage treatment for patients with multiple sclerosis and lymphopenia or neutropenia. Mult Scler 19(9):1244-1245